• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Mezzion Announces Dr. Rahul Rathod of Boston Children`s Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2

    PR NEWSWIRE

    Mezzion Pharma Raises Nearly $40M to Advance Option for Fontan Patients

    PR NEWSWIRE

    Mezzion Submits Protocol for Confirmatory Pivotal PIII Trial in Fontan Subjects

    PR NEWSWIRE

    Mezzion Pharma Receives Clear FDA Path Forward for the Approval of Udenafil

    PRNEWSWIRE

    Mezzion`s New Drug Application ("NDA") for its Orphan Drug Udenafil for ("SVHD")

    PRNEWSWIRE

    Mezzion Announces Re-Submission of NDA for its Orphan Drug Udenafil

    PRNEWSWIRE

    Mezzion Announces Submission of New Drug Application for its Orphan Drug Udenafi

    PRNEWSWIRE

    Mezzion Pharma announces Top Line Data from FUEL will be presented AHA

    PR NEWSWIRE

    Mezzion Pharma announces that it has conducted a Type C Meeting with the FDA

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.